| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |